The first part of the study included an analysis of both treated and untreated JDM children, while the second part focused specifically on untreated JDM children to determine if an elevated vWF:Ag is associated with more severe JDM clinical manifestations than JDM with a normal vWF:Ag level. This evidence concerns the gene RENBP and juvenile dermatomyositis.